Fundraising FoxSlater Technology Fund — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Octagon Therapeutics is a biotech company developing new medicines for autoimmune diseases with unmet clinical need, based on scientific research from Harvard.
BiotechHealthtechProvidence, US
Isaac Stoner(Co-founder & CEO)inFred Ausubel(Co-founder; Professor of Genetics, Harvard Medical School (Emeritus))Ronald Lennox(Director)
Board seatThorne Sparkman· per SEC Form D
Co-investorsBantam GroupSand Hill AngelsWalnut Venture Associates
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.